BSC
REGN icon

BOLTON SECURITIES CORPORATION’s Regeneron Pharmaceuticals REGN Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$401K Sell
529
-184
-26% -$139K 0.02% 663
2026
Q2 		$445K Buy
713
+511
+253% +$348K 0.02% 641
2026
Q1 		$156K Buy
+202
New +$155K 0.01% 880
2025
Q3 		$103K Buy
+184
New +$104K ﹤0.01% 948
2025
Q1 		$103K Buy
+163
New +$112K 0.01% 863

Other funds holding REGN

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's REGN Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Regeneron Pharmaceuticals (REGN) stake by 26% in Q3 2026, selling an estimated $139K and leaving 529 shares worth $401K. The position accounts for 0.02% of the portfolio, ranked #663.

BOLTON SECURITIES CORPORATION first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $445K in Q2 2026. 1,006 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 529 shares of Regeneron Pharmaceuticals worth $401K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION sold 184 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $139K.
  • Regeneron Pharmaceuticals made up 0.02% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #663 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • BOLTON SECURITIES CORPORATION's Regeneron Pharmaceuticals position peaked at $445K in Q2 2026.
  • 1,006 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.